全球药物释放型球囊导管市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，药物释放型球囊导管市场规模将从 2025 年的 12.2 亿美元成长至 26.9 亿美元，2026 年至 2034 年的复合年增长率为 9.16%。

受心血管疾病盛行率上升和微创手术需求增加的推动，全球药物释放型球囊导管市场正经历稳定成长。这些导管广泛应用于冠状动脉和周边动脉疾病的治疗，因为它们能将药物直接输送到动脉壁，同时降低血管再阻塞的风险。患者和医生对先进介入技术的认知不断提高，也进一步促进了市场扩张。

推动成长要素包括全球人口老化、导致心臟病的不健康生活方式以及导管设计技术的进步。由于药物释放型球囊技术相比传统支架具有恢復时间更短、併发症更少的优势，因此医院和专科心臟中心正越来越多地采用该技术。医疗设备製造商持续不断的研发活动也促进了产品性能和安全性的提升。

展望未来，新兴国家医疗基础设施的改善以及介入性心臟手术保险覆盖范围的扩大预计将对市场产生积极影响。药物製剂和联合治疗的创新有望进一步改善临床疗效。随着全球对微创治疗的需求持续成长，药物释放型球囊导管预计仍将是血管疾病治疗的重要解决方案。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球药物释放型球囊导管市场：依产品类型划分

• 市场分析、洞察与预测
• 紫杉醇药物洗脱球囊导管
• Sirolimus药物洗脱球囊导管

第五章：全球药物释放型球囊导管市场：依适应症划分

• 市场分析、洞察与预测
• 冠状动脉介入治疗
• 週边干预

第六章 全球药物释放型球囊导管市场：依最终用户划分

• 市场分析、洞察与预测
• 医院及门诊手术中心
• 导管检查室
• 其他的

第七章 全球药物释放型球囊导管市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Meril Life Sciences Pvt. Ltd
  • Medtronic
  • Eurocor Tech GmbH
  • Zhejiang Barty Medical Technology Co. Ltd
  • Biotronik
  • IVascular
  • Lepu Medical Technology（Beijing）Co. Ltd
  • Concept Medical
  • Koninklijke Philips NV

The Drug-eluting Balloon Catheters Market size is expected to reach USD 2.69 Billion in 2034 from USD 1.22 Billion (2025) growing at a CAGR of 9.16% during 2026-2034.

The Global Drug-eluting Balloon Catheters Market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive procedures. These catheters are widely used in treating coronary and peripheral artery diseases, as they deliver medication directly to the arterial wall while reducing the risk of restenosis. Growing awareness among patients and physicians about advanced interventional techniques is further contributing to market expansion.

Key drivers include the aging global population, unhealthy lifestyles leading to heart disorders, and technological advancements in catheter design. Hospitals and specialty cardiac centers are increasingly adopting drug-eluting balloon technologies because they offer shorter recovery times and fewer complications compared to traditional stents. Continuous research and development activities by medical device companies are also enhancing product performance and safety profiles.

Looking ahead, the market is expected to benefit from improved healthcare infrastructure in emerging economies and expanding reimbursement coverage for interventional cardiology procedures. Innovation in drug formulations and combination therapies will likely strengthen clinical outcomes. As demand for minimally invasive treatments continues to rise globally, drug-eluting balloon catheters are projected to remain an important solution in vascular disease management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Paclitaxel Drug-Eluting Balloon Catheters
• Sirolimus Drug-Eluting Balloon Catheters

By Indication

• Coronary Intervention
• Peripheral Intervention

By End User

• Hospitals and ASCs
• Catheterization Laboratories
• Others

COMPANIES PROFILED

• Becton Dickinson and Company, , Meril Life Sciences Pvt Ltd, Medtronic, Eurocor Tech GmbH, Zhejiang Barty Medical Technology Co Ltd, Biotronik, iVascular, Lepu Medical Technology Beijing Co Ltd, Concept Medical, Koninklijke Philips NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Paclitaxel Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sirolimus Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Coronary Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and ASCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG-ELUTING BALLOON CATHETERS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Meril Life Sciences Pvt. Ltd
  • 9.2.2 Medtronic
  • 9.2.3 Eurocor Tech GmbH
  • 9.2.4 Zhejiang Barty Medical Technology Co. Ltd
  • 9.2.5 Biotronik
  • 9.2.6 IVascular
  • 9.2.7 Lepu Medical Technology (Beijing) Co. Ltd
  • 9.2.8 Concept Medical
  • 9.2.9 Koninklijke Philips N.V